Latest Convertible Notes News

Native Mineral Resources Holdings Limited reported significant cash outflows in its June quarter, offset by a recent $10 million share placement aimed at supporting its Blackjack Milling gold project development.

Native Mineral Resources has completed its first gold pour at the Blackjack Gold Project, marking a key milestone as it advances toward full production ramp-up in August 2025. The company also secured a $10 million placement to support its growth plans.

Novatti Group reported a record $14.3 million quarterly revenue in Q4 FY25, marking a clear shift back to growth after streamlining operations and focusing on higher-margin opportunities. The company’s platform upgrade and leadership changes set the stage for stronger financial performance ahead.

XPON Technologies reported a strong Q4 FY25 with a 27% revenue jump driven by its Alpha Digital acquisition, while targeting positive EBITDA and cash flow from Q2 FY26.

NT Minerals has advanced key asset sales including the Mountain Home and Redbank/Wollogorang projects, while facing a critical cash position and awaiting shareholder approval for its latest disposal deal.

NEXION Group Ltd has exited a major transaction, sold its Perth data centre, and relaunched its AI-focused subsidiary, positioning itself for renewed growth and ASX reinstatement.

Sprintex has advanced a promising trial with a major Dutch agribusiness, potentially unlocking €4.8 million in sales, while also securing a significant private-label contract in China’s booming aquaculture sector.

Genmin Limited’s latest quarterly cash flow report reveals significant cash outflows and a critical liquidity shortfall, prompting urgent funding measures including new loans and convertible notes.

NH3 Clean Energy has made significant strides in its flagship WAH2 low-emission ammonia project, signing pivotal agreements on carbon capture and ammonia bunkering while strengthening its financial position.

Mont Royal Resources is progressing its merger with Commerce Resources to create a dual-listed Canadian critical metals developer, combining rare earth and lithium assets in Quebec.

Zelira Therapeutics reports promising diabetic neuropathy study results with ZLT-L-007 surpassing Lyrica, while converting $3.25 million in notes to equity to bolster HOPE® 1 clinical development.

The Star Entertainment Group reported steady Q4 FY25 revenue of $270 million but widened its EBITDA loss to $27 million, reflecting ongoing regulatory pressures and operational challenges. The company secured $233 million from strategic investors Bally’s Corporation and Investment Holdings, while negotiations continue over its Brisbane joint venture exit.